Product Overview
VITARAN i is a BR PHARM Co., Ltd. polynucleotide product containing Polynucleotide Sodium 20mg/mL in a 1ml syringe. The single-syringe presentation is compared below with VITARAN and VITARAN s. These three formulations share the same declared ingredient strength, while the compared presentations differ in package count and qualitative viscosity.
Composition & Specifications
| Specification | VITARAN i |
|---|---|
| Declared ingredient | Polynucleotide Sodium 20mg/mL |
| Volume per syringe | 1ml |
| Packaged presentation | 1 syringe per box |
| Manufacturer | BR PHARM Co., Ltd. |
| Country of origin | South Korea |
Variant Presentations
VITARAN i, VITARAN and VITARAN s each declare Polynucleotide Sodium at 20 mg/mL. Their qualitative viscosity ordering is i, VITARAN, then s, from lower to higher within this comparison; this does not specify numerical rheology, molecular weight or particle size.
| Variant | Volume per syringe | Compared package | Relative viscosity |
|---|---|---|---|
| VITARAN i | 1ml | 1 syringe per box | Lower |
| VITARAN | 1mL | 2 pre-filled syringes per box | Intermediate |
| VITARAN s | 1mL | 1 pre-filled syringe per box | Higher |
Package configurations shown here describe the compared presentations and may differ between market versions.
